Cullinan Oncology LLC
Price & Volume
Stats
See more52W Range | $5.68-$16.74 |
Market Cap | $923.7M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$3.37 |
News
See moreYahoo Finance • 13 days ago
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
Yahoo Finance • 15 days ago
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Yahoo Finance • 3 months ago
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Yahoo Finance • 4 months ago
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
About
CEO | Mr. Nadim Ahmed M.S. |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |